Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2013

View Archived Issues

Novel LM-Kras vaccine delays progression of pancreatic intraepithelial neoplasia in vivo

Potential new treatment for patients susceptible to lactic acidosis

Novel protein Wnt signaling inhibitors synthesized at Samumed

Development of novel ERK inhibitor SCH-772984 reported

Bayer presents BAY-ACC001 as a potent and selective AAC inhibitor

AstraZeneca reports on novel ATR inhibitor AZD-6738

New protein kinase inhibitors designed by Merck KGaA

Sanofi develops novel DGAT1 inhibitors for metabolic disorders

GR modulators show promise in models of respiratory diseases

Abbott obtains CE mark for galectin-3 heart failure test

Johns Hopkins University patents new chymase inhibitors

Sanofi Pasteur's quadrivalent influenza vaccine accepted for review in Europe

Quest Diagnostics launches new tests for rheumatoid arthritis

VereFlu detects current H7N9 avian flu subtype

Sarepta Therapeutics and UWA expand agreement for exon-skipping program

Lundbeck designs novel mGlu5 receptor allosteric modulators

Avioq launches Avioq HTLV-I/II test in Europe

Photocure reports final results from phase IIb study of Cevira

Gamida Cell reports results from final analyses of phase II/III study of StemEx

Novel NS5B inhibitors disclosed by Biota Scientific Management

Confirmatory phase III study not required for filing pimavanserin NDA

New CDK9/cyclin-T1 inhibitors divulged by Bayer Intellectual Property

Sarah Cannon Research Institute to conduct phase II study of OGX-427

First European launch for Jetrea in U.K.

Aptalis launches Pylera in France

FDA accepts Varisolve NDA for full review

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...